{"id":3833,"date":"2017-01-20T12:26:46","date_gmt":"2017-01-20T12:26:46","guid":{"rendered":"https:\/\/www.wma.net\/wp-content\/uploads\/2017\/01\/Presentation_on_DoH-_Mfutso-Bengo.pdf"},"modified":"2017-01-20T12:26:46","modified_gmt":"2017-01-20T12:26:46","slug":"presentation_on_doh-_mfutso-bengo-2","status":"inherit","type":"attachment","link":"https:\/\/www.wma.net\/es\/presentation_on_doh-_mfutso-bengo-2\/","title":{"rendered":"Presentation_on_DoH-_Mfutso-Bengo"},"author":2,"comment_status":"open","ping_status":"closed","template":"","meta":[],"acf":[],"description":{"rendered":"<p class=\"attachment\"><a href='https:\/\/www.wma.net\/wp-content\/uploads\/2017\/01\/Presentation_on_DoH-_Mfutso-Bengo.pdf'>Presentation_on_DoH-_Mfutso-Bengo<\/a><\/p>\n<p>Prof. J. Mfutso-Bengo, PhD<br \/>\nCenter of Bioethics (CEBESA)<br \/>\nUniversity of Malawi College of Medicine<br \/>\nCapeTown \u2013 South Africa<br \/>\nDecember 2012<br \/>\nwww.medcol.mw<br \/>\nJoseph-matthew@gmx.net<br \/>\nRevisions on the Declaration of<br \/>\nHelsinki<br \/>\nIntroduction<br \/>\n\uf097 TheWorld Medical Association (WMA)was<br \/>\nestablished after theWW2 in reaction to the<br \/>\natrocities committed by physicians<br \/>\n\uf097 It was meant to be a global representative body for<br \/>\nphysicians<br \/>\n\uf097 Currently, there are 48 National Medical<br \/>\nAssociations and approximately 7 million physicians<br \/>\n\uf097 WMA adopted the Declaration of Helsinki (DoH) in<br \/>\n1964<br \/>\nThe Roles of the WMA in Biomedical<br \/>\nResearch<br \/>\n\uf097 Establishment of high-level global ethical<br \/>\nstandards for biomedical research<br \/>\n\uf097 Bridge between physicians and researchers<br \/>\n\uf097 Advocate for patients serving as human<br \/>\nsubjects<br \/>\n\uf097 Participant in capacity-building initiatives<br \/>\nBrief History of DoH<br \/>\n\uf097 First adopted in 1964<br \/>\n\uf097 Significant additions in 1975<br \/>\n\uf097 Minor amendments in 1983, 1989 and 1996<br \/>\n\uf097 Major revision and reorganization 2000<br \/>\n\uf097 Notes of clarification in 2002 and 2004<br \/>\n\uf097 Another revision in 2008<br \/>\nInfluence of DoH<br \/>\n\uf097 CIOMS guidelines follow the DoH quite closely<br \/>\n\uf097 ICH-GCP guidelines require adherence to \u201cprinciples<br \/>\nthat have their origin in the DoH\u201d<br \/>\n\uf097 The UNESCO Declaration on Bioethics and Human Rights<br \/>\ncites the DoH<br \/>\n\uf097 The EC Directive on ClinicalTrials and the US FDA<br \/>\nrequire adherence to the principles of DoH<br \/>\n\uf097 DoH is the most cited research ethics document by<br \/>\nresearch ethics committees<br \/>\nProposed Amendments in the 2012<br \/>\nConsultation Draft<br \/>\n\uf097 Paragraph 11: It should be revised to read;\u201cIt is the duty of<br \/>\nthe researcher in medical research to protect the life,<br \/>\nhealth, privacy, confidentiality and dignity of the<br \/>\nhuman subject\u201d<br \/>\n\uf097 Paragraph 12: It should be revised to read;\u201cAppropriate<br \/>\ncaution must be exercised in the conduct of research which<br \/>\nmay affect the environment, and the welfare of human<br \/>\nsubjects and animals used for research must be respected.\u201d<br \/>\nProposed Amendments in the 2012<br \/>\nConsultation Draft<br \/>\n\uf097 Article 14 the ethics committee should provide the<br \/>\nresearchers with a checklists of documentation and<br \/>\nrequirements for independent scientific and ethical review<br \/>\nprocess<br \/>\n\uf097 The researcher should also submit to the committee, for<br \/>\nreview, information regarding funding, sponsors, institutional<br \/>\nAffiliations, other potential conflicts of interest and<br \/>\nincentives for subjects. I propose to add \u201cPost trial access<br \/>\nplan if appropriate and community engagement<br \/>\nplan.\u201d<br \/>\nProposed Amendments in the 2012<br \/>\nConsultation Draft cont\u2019d<br \/>\n\uf097 Paragraph 28: It should be revised to read:\u201c<br \/>\nWhen a subject deemed legally incompetent,<br \/>\nsuch as a minor child, is able to give assent to<br \/>\ndecisions about participation in research, the<br \/>\ninvestigator must obtain that assent in addition to<br \/>\nthe consent of the legally authorized<br \/>\nrepresentative. However, emancipated<br \/>\nminors should be allowed to give their<br \/>\nown informed consent.\u201d e.g., minors who<br \/>\nare mothers.<br \/>\nProposed Amendments in the 2012<br \/>\nConsultation Draft cont\u2019d<br \/>\n\uf097 Paragraph 31: It should be revised to read;\u201cThe physician<br \/>\nshould fully inform the patient which aspects of the care<br \/>\nare related to the research.The refusal of a patient to<br \/>\nparticipate in a study must never interfere with the<br \/>\npatient-physician relationship. And if a conflict of<br \/>\ninterest (CoI) exists between a physician cum<br \/>\nresearcher and a patient, the physician must<br \/>\ndisclose the CoI to the patient and recuse<br \/>\nhim\/herself from recruiting the patient as a<br \/>\nhuman subject.\u201d<br \/>\nProposed additional principle<br \/>\n\uf097 Paragraph : \u201cHuman subjects who<br \/>\nparticipate in clinical trials involving<br \/>\ninvestigational products whose safety<br \/>\nprofiles are unknown should be<br \/>\nprovided with clinical trials<br \/>\ninsurance\u201d<br \/>\nExportation and importation of clinical<br \/>\nand research samples<br \/>\n\uf097 There is growing trend of exporting human tissues from developing countries to laboratories in<br \/>\ndeveloped countries for clinical diagnosis or clinical research. Especially for clinical samples have<br \/>\nthe potential for abuse and lack of accountability<br \/>\n\uf097 There is need to create safeguards to avoid the abuse of those human tissues.<br \/>\n\uf097 Hence we propose that there is a need to have a material transfer agreement(MTA).<br \/>\n\uf097 The MTA agreement form should have a clear description of namely:<br \/>\n1. The destination<br \/>\n2. Ownership<br \/>\n3. The intention of export\/import<br \/>\n4. Access and control of the samples<br \/>\n5. Safety and security of the samples<br \/>\n6. Capacity building issues<br \/>\n7. Justification<br \/>\n8. Permission<br \/>\n9. Signatures<br \/>\nHow to resolve conflicting decisions<br \/>\nbetween ethics committees in multi-<br \/>\ncentered clinical trial<br \/>\n\uf097 Incase of conflict between a remote and a local ethics<br \/>\ncommittee.The voice of the local ethics committee ought to be<br \/>\ntaken into consideration<br \/>\n\uf097 The scientific and ethical justification should not be ignored<br \/>\nConditions for supporting local ethical<br \/>\njurisdictions<br \/>\n1. Members of the local population and, in this situation, the local ethical<br \/>\ncommittee is the best judge of what is appropriate<br \/>\n2. Exception: local review is sufficient only if the host country\/institution<br \/>\nhas a system of substantive protections that are equivalent to international<br \/>\nacceptable standards.<br \/>\n3. The basis of this argument is the principle of justice: that equals should be<br \/>\ntreated equally. Local ethical committees should be allowed to adjudicate<br \/>\nconflicts between remote and local committees, One approach to<br \/>\nresolving the impasse could be to distinguish between fundamental,<br \/>\nqualitative and non-arguable principles and more relative, quantitative and<br \/>\ncircumstantial applications.<br \/>\n\uf097 (6) Ethical principles cannot be universal without being contextual<br \/>\nConditions for supporting local ethical<br \/>\njurisdictions<br \/>\n\uf097 (1)The local committee must be constituted and its deliberations<br \/>\nexecuted according to internationally recognized ethical standards<br \/>\n(e.g.TheWorld MedicalAssociation&#8217;s Declaration of Helsinki;The<br \/>\nBelmont Report: Ethical Principles*).<br \/>\n\uf097 A clear SOPs of decision-making process<br \/>\n\uf097<br \/>\nConclusion<br \/>\n\uf097 Developing countries are vulnerable to<br \/>\nunscrupulous researchers<br \/>\n\uf097 Collective responsibility in protecting the rights,<br \/>\nsafety, and welfare of human subjects is critical.<br \/>\n\uf097 This calls for fair and objective regulations and<br \/>\nguidelines that aim at promoting research and<br \/>\ndevelopment while at the same time not<br \/>\ncompromising the protection of human subjects<\/p>\n"},"caption":{"rendered":"<p>Presentation_on_DoH-_Mfutso-Bengo Prof. J. Mfutso-Bengo, PhD Center of Bioethics (CEBESA) University of Malawi College of Medicine CapeTown \u2013 South Africa December 2012 www.medcol.mw Joseph-matthew@gmx.net Revisions on the Declaration of Helsinki Introduction \uf097 TheWorld Medical Association (WMA)was established after theWW2 in reaction to the atrocities committed by physicians \uf097 It was meant to be a global representative [&hellip;]<\/p>\n"},"alt_text":"","media_type":"file","mime_type":"application\/pdf","media_details":{},"post":null,"source_url":"https:\/\/www.wma.net\/wp-content\/uploads\/2017\/01\/Presentation_on_DoH-_Mfutso-Bengo.pdf","_links":{"self":[{"href":"https:\/\/www.wma.net\/es\/wp-json\/wp\/v2\/media\/3833"}],"collection":[{"href":"https:\/\/www.wma.net\/es\/wp-json\/wp\/v2\/media"}],"about":[{"href":"https:\/\/www.wma.net\/es\/wp-json\/wp\/v2\/types\/attachment"}],"author":[{"embeddable":true,"href":"https:\/\/www.wma.net\/es\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.wma.net\/es\/wp-json\/wp\/v2\/comments?post=3833"}]}}